Light on your forehead, a sleep score, and AI going mad

Shining near-infrared light on your forehead improved sleep in a small trial

One in three college students can't sleep well — could seven sessions of near-infrared light aimed at your forehead change that?

A team in China ran a randomized controlled trial — the gold standard of medical testing — on 37 college students with insomnia. Half got 10 minutes a day of near-infrared laser light aimed at a spot just above their right eyebrow, for seven days. The other half got a sham device that looked identical. Think of the prefrontal cortex — the front part of your brain that handles braking and self-regulation — like the brake pedal in a car. In people with insomnia, this region tends to be underactive, which means the brain's racing-thought engine never gets properly slowed down. The idea is that the light nudges that stuck brake back into service. Sleep quality scores on two standard clinical scales (the PSQI and ISI — both questionnaires your GP might use) improved significantly in the treatment group. The effect sizes were meaningful — roughly 0.93 to 1.27 on a standard scale where anything above 0.8 is considered large — and they grew over the two weeks after treatment ended. Not a one-day blip. Brain wave recordings backed this up: delta waves, associated with mental noise and sleep pressure, dropped in the treatment group; alpha waves, associated with calm wakefulness, rose. A mediation analysis confirmed that these brain-wave shifts were actually on the path between the light and the sleep improvement, not a coincidence. Why it matters: insomnia is a well-documented doorway into depression and anxiety. A non-drug option with effects that build after the treatment ends is genuinely worth watching. The catch: 37 people is very small. Patients could likely tell whether their device was real — so it was single-blind, not double-blind. All participants were college students at one location, treated for one week. We do not know whether this works in people with more severe conditions, older adults, or anyone outside this setting. Call it a promising pilot, not a prescription.

One number from your sleep and movement data could flag depression risk

What if a single number — derived from when you sleep, nap, and move — could detect depression risk as well as a full clinical battery?

A team analyzing data from 15,233 older adults in China wanted to compress a messy pile of behavioral measurements — sleep timing, nap length, physical activity, social engagement — into a single number that still carries predictive power for depression. They call it the Circadian Rhythm Score, or CRS. Think of it like a credit score: your credit score collapses dozens of financial behaviors into one number a lender can act on quickly. The CRS does the same for your body clock. Using a machine learning method called gradient-boosted trees (a technique that builds many small decision rules and combines them), the team found the CRS could flag depression with an accuracy — measured as AUC, where 1.0 is perfect and 0.5 is a coin flip — of up to 0.83 in adults in their 70s, competitive with using the raw multi-variable dataset. Along the way, they surfaced some concrete thresholds worth noting: a minimum effective exercise dose of roughly 300 metabolic-equivalent minutes per week (that's about 60 minutes of brisk walking, five days a week), an optimal restorative nap of around 65 minutes for sleep-deprived people, and a protective sleep duration window of approximately 6 hours. Why it matters: if a wearable or a short phone survey can generate a CRS, you have a scalable, low-cost way to flag people who might benefit from outreach — no clinic required. The catch: this is observational data from a Chinese cohort of adults over 45. The thresholds may not transfer to younger people or other populations. An AUC of 0.83 still means a real error rate. This is a screening signal, not a diagnosis — and the difference matters enormously.

Scientists gave AI agents seven mental illnesses to learn how disorders work

Turn one dial in an AI's reward system and it develops what looks like anxiety; turn it the other way and you get something that looks like mania.

A research team built a kind of AI agent — a simple program that learns by trial and error, like training a dog with treats — and then asked what happens when you tamper with how it values situations. They added six internal commentary signals that shape the agent's sense of whether a situation is threatening, controllable, or rewarding. By adjusting a single continuous dial on each signal, they induced behavioral patterns that mirror seven psychiatric conditions: anxiety, mania, OCD, depression, impulsivity, addiction, and PTSD. Think of it like the bass slider on a music equalizer. One slider controls how much low-end frequency the speakers produce. Push it too high and everything sounds overwhelming and distorted. Pull it too low and everything sounds thin and consequence-free. The psychiatric disorders showed up as different miscalibrations of different sliders — and crucially, they came in dose-response curves. A small distortion produced mild symptoms; a larger distortion produced severe ones. That's exactly the graduated severity you see in real clinical populations. The team also found that different disorders responded to different fixes. Turning the dial back to neutral resolved mania and addiction-like behaviors. But anxiety and PTSD analogs only recovered when the agent went through something resembling graduated exposure therapy — facing the thing it feared, step by step — not when the dial was simply removed. Why it matters: this is a controlled sandbox for testing theories about what causes psychiatric conditions and what might treat them — without a single human participant involved. The catch: an AI agent is not a brain. Behavioral resemblance is not the same as shared mechanism. No one is claiming these agents feel anything. The value is structural — a tool for stress-testing ideas. How well the underlying math maps onto actual neuroscience is still wide open.

Three different angles today, but one quiet theme running through all of them: the field is building better instruments. The circadian rhythm work says your behavioral patterns are a legible signal — if you know how to compress and read them. The light-therapy trial says a brief, physically targeted nudge to a specific brain region can shift those signals in a measurable, lasting direction. The AI disorder paper says we now have a controlled sandbox where psychiatric theories can be tested, broken, and refined without ethical constraints. Together, they sketch a picture of mental health research moving — slowly, imperfectly — away from 'depression is a feeling you treat with a pill' toward something more structural: a condition you can detect early from wearable data, probe computationally in a virtual environment, and potentially treat through precise physical or behavioral intervention. That shift is real. It is also years, maybe decades, from your doctor's office.

The tPBM sleep trial is small enough that a larger, properly double-blinded replication would be the meaningful next step — worth watching for in the coming year. On the computational psychiatry side, the logical next move is testing whether the 'exposure therapy' finding in RL agents holds up in more complex virtual environments, which the team has already begun with a 3D setting. More broadly, if anyone announces a preregistered circadian biomarker study in a Western population using wearables, that would be the real test of whether the CRS thresholds travel.

• Wikipedia: Photobiomodulation — background on the light therapy technique
• Wikipedia: Circadian rhythm — the biological basis of the CRS approach
• Wikipedia: Computational psychiatry — the broader field the RL agent paper sits in